FDA Releases Draft Guidance on Indications and Usage Labeling Sections
On July 9, 2018, the United States Food and Drug Administration (FDA) issued draft guidance entitled, “Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products – Content and Format.” The guidance is intended to assist applicants in writing their Indications and Usage section of product labeling for new drugs as…
Read More...
